Monthly Scientific Update – February 2023

LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote cell growth. One of these pathways is known as the Hippo signaling pathway, which involves the activation of “yes-associated protein” (YAP). YAP is regulated by another protein called LCK, which can turn on YAP through…

Read More